Squamous cell carcinoma of the endometrium with human papillomavirus type 31 and without tumor suppressor gene p53 mutation

被引:35
|
作者
Kataoka, A [1 ]
Nishida, T [1 ]
Sugiyama, T [1 ]
Hori, K [1 ]
Honda, S [1 ]
Yakushiji, M [1 ]
机构
[1] TOKYO MED COLL,DEPT OBSTET & GYNECOL,TOKYO 160,JAPAN
关键词
D O I
10.1006/gyno.1996.4597
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Primary squamous cell carcinoma of the endometrium (ESCC) is extremely rare. There has been no report of human papillomavirus (HPV) detected in ESCC. A 64-year-old Japanese female underwent total abdominal hysterectomy, bilateral salpingo-oophorectomy, and dissection of the pelvic, para-aortic, and bilateral inguinal lymph nodes. The tumor was confined to the endometrium, without invasion of myometrium or cervix. The endometrium was seen to be replaced by moderately differentiated squamous cell carcinoma, without any adenocarcinomatous element. Polymerase chain reaction amplification produced a 244- to 256-bp DNA fragment from the L1 region of the HPV genome. The amplification products were restricted, and the restricted fragment length polymorphism patterns were analyzed. The squamous cell carcinoma DNA was amplified for each exon, 5 through 8, of the p53 gene. The amplification products were used in single-stranded conformation polymorphism analysis. The tumor described showed the presence of HPV DNA. This amplified fragment was further purified by extraction from agarose gel, and the DNA was sequenced. Comparison of the fragment DNA sequence with known PV sequences showed that it had been amplified from HPV type 31. This is the first detection of HPV DNA in ESCC. Despite previous reports, HPV cannot not be excluded as a possible factor in the development of the malignancy. (C) 1997 Academic Press.
引用
收藏
页码:180 / 184
页数:5
相关论文
共 50 条
  • [41] Presence of human papillomavirus in esophageal squamous cell carcinomas of Hong Kong Chinese and its relationship with p53 gene mutation
    Lam, KY
    He, D
    Ma, L
    Zhang, DK
    Ngan, HYS
    Wan, TSK
    Tsao, SW
    [J]. HUMAN PATHOLOGY, 1997, 28 (06) : 657 - 663
  • [42] P53 - A TUMOR-SUPPRESSOR GENE
    WUSTROW, TPU
    [J]. HNO, 1993, 41 (05) : A12 - A13
  • [43] P53 - THE ULTIMATE TUMOR SUPPRESSOR GENE
    OREN, M
    [J]. FASEB JOURNAL, 1992, 6 (13): : 3169 - 3176
  • [44] THE P53 TUMOR-SUPPRESSOR GENE
    LEVINE, AJ
    CHANG, AW
    DITTMER, D
    NOTTERMAN, DA
    SILVER, A
    THORN, K
    WELSH, D
    WU, M
    [J]. JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1994, 123 (06): : 817 - 823
  • [45] THE P53 TUMOR SUPPRESSOR GENE AND PRODUCT
    LEVINE, AJ
    [J]. CANCER SURVEYS, 1992, 12 : 59 - 79
  • [46] Enigmas of p53 tumor suppressor gene
    Belousova, AK
    [J]. EXPERIMENTAL ONCOLOGY, 1996, 18 (03): : 197 - 207
  • [47] Mutation of tumor suppressor gene p53 in hepatocellular carcinomas from Korea
    Park, YM
    Yoo, YD
    Paik, SY
    Kim, BS
    Tabor, E
    [J]. EXPERIMENTAL AND MOLECULAR MEDICINE, 1996, 28 (04): : 173 - 179
  • [48] A UVB fingerprint mutation on the p53 tumor suppressor gene decreases in vitro
    Zhang, Zhiyuan
    Burger, Katharina
    Hellwig, Sven
    Bergemann, Joerg
    [J]. CELLS TISSUES ORGANS, 2008, 188 (03) : 280 - 286
  • [49] THE P53 TUMOR-SUPPRESSOR GENE
    LEVINE, AJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (20): : 1350 - 1352
  • [50] p53 mutation, but not p53 overexpression, correlates with survival in head and neck squamous cell carcinoma
    Mineta, H
    Borg, Å
    Dictor, M
    Wahlberg, P
    Åkervall, J
    Wennerberg, J
    [J]. BRITISH JOURNAL OF CANCER, 1998, 78 (08) : 1084 - 1090